Background: Patients with pathological stage IA adenocarcinoma (AC) have a variable
prognosis, even if treated in the same way. The postoperative treatment of pathological stage IA …

… not adequately risk stratify patients with early stage non–small cell lung cancer. We sought to
… in patients with early stage lung adenocarcinoma, the dominant histology of lung cancer in …

… development of early-stage lung adenocarcinoma. Methods: Tumor samples and paired
adjacent normal tissues from 4 patients with early-stage lung adenocarcinoma were selected to …

… (ACT) among stage IB lung adenocarcinoma patients. This study aimed … lung adenocarcinoma
classification system on benefit of ACT among patients with stage IB lung adenocarcinoma…

… lung adenocarcinoma (LUAD). Univariate overall survival analyses by optimised cut-offs of a)
LUAD patients by single markers and b) all lung cancer patients … Data are shown as patient …

… Patient Population In this study, we reviewed surgical specimens from all of the 141 patients
diagnosed with lung adenocarcinoma, … All cases were from patients with clinical American …

… In this study, stage IV lung adenocarcinoma patients who developed MPEs following disease
progression showed longer overall survival than those with MPEs at initial diagnosis. This …

… The patient cohort presented in this study … patients with stages II and III lung adenocarcinoma
in our data set as this represented an obvious heterogeneity, especially in stage III patients. …

… of patients with lung adenocarcinoma and identified specific genes that predict survival among
patients with stage I … survival in an independent cohort of stage I lung adenocarcinomas. …

… stage I lung adenocarcinoma … patients with stage IB lung adenocarcinoma. A subgroup with
a better outcome was identified and their survival was compared with that of stage IA patients…